Skip to content
BranchLab
  • Home
  • Data SolutionsExpand
    • Advertisers
    • Publishers
    • HealthGraph™
  • About
  • Resources
  • Careers
Log In
Contact Us
BranchLab

News and Insights

News and Insights from the world of BranchLab.

News and Insights

Insights

Why Banning Health Data Tracking Benefits Everyone, Even Advertisers

April 23, 2025April 23, 2025

by Josh Walsh, Co-Founder & CEO, BranchLab A recent Harvard Law publication warns that Washington’s My Health My Data Act (WMHMD) could disrupt widely used advertising techniques. It’s right. And…

Read More Why Banning Health Data Tracking Benefits Everyone, Even AdvertisersContinue

Insights

Protecting Patients and Performance

April 9, 2025April 10, 2025

As regulations tighten, cleanroom technology offers a sustainable, compliant path forward for health advertising. The advertising technology ecosystem is at a crossroads. Eighty percent of consumers are concerned and confused…

Read More Protecting Patients and PerformanceContinue

After FTC Commissioners Fired, Marketers Speculate on Future of Industry Regulation
News

After FTC Commissioners Fired, Marketers Speculate on Future of Industry Regulation

March 24, 2025March 24, 2025

BranchLab CEO, Josh Walsh, weighs in on the role state regulations will play for marketers, especially pharma advertisers, in the vacuum of federal regulation.

Read More After FTC Commissioners Fired, Marketers Speculate on Future of Industry RegulationContinue

Insights

How New York’s Recent Health Data Privacy Law Impacts Pharma Advertising 

February 12, 2025February 12, 2025

The advertising landscape is changing, especially for healthcare and pharmaceutical companies. This January, the New York Senate approved S929 – a groundbreaking data privacy law and significant step towards greater…

Read More How New York’s Recent Health Data Privacy Law Impacts Pharma Advertising Continue

20 Ad Tech Executives Predict 2025 Trends
News

20 Ad Tech Executives Predict 2025 Trends

January 20, 2025January 20, 2025

BranchLab’s Michael Parkes predicts: “State privacy regulations, such as Washington’s My Health My Data Act, will profoundly reshape pharmaceutical advertising by imposing strict limitations on the use of health data….

Read More 20 Ad Tech Executives Predict 2025 TrendsContinue

Insights

Could Washington State Transform Pharmaceutical Advertising Forever?

December 18, 2024December 20, 2024

Unpacking the Pivotal Harvard Law Paper. Pharmaceutical advertising is undergoing a seismic shift, and Washington State is at the epicenter. A recent paper from Harvard Law has issued a transformative…

Read More Could Washington State Transform Pharmaceutical Advertising Forever?Continue

Is Targeted Pharma Advertising Over? Not Quite
News

Is Targeted Pharma Advertising Over? Not Quite

December 10, 2024December 11, 2024

BranchLab’s Michael Parkes provides an overview of the emerging state regulations impacting the media strategies of pharmaceutical and healthcare brands, offering recommendations on how to navigate a new era of…

Read More Is Targeted Pharma Advertising Over? Not QuiteContinue

Health and Wellness Brands Brace for Ad Restrictions on Meta
News

Health and Wellness Brands Brace for Ad Restrictions on Meta

December 6, 2024December 10, 2024

BranchLab CEO, Josh Walsh, weighs in on Meta’s move to implement stricter policies for health and wellness brands.

Read More Health and Wellness Brands Brace for Ad Restrictions on MetaContinue

Insights

What could a new administration mean for healthcare advertising?

November 25, 2024November 25, 2024

RFK Jr. has consistently advocated for a ban on pharmaceutical advertising, as evidenced by his discussions on prominent platforms like The Joe Rogan Experience and his social media posts, including…

Read More What could a new administration mean for healthcare advertising?Continue

No More TV Drug Ads? Don’t Hold Your Breath
News

No More TV Drug Ads? Don’t Hold Your Breath

November 22, 2024December 6, 2024

Does the incoming Trump administration and RFK Jr.’s potential appointment as the head of Health and Human Services (HHS) spell the end of TV drug ads? Probably not, argues Josh Walsh, CEO…

Read More No More TV Drug Ads? Don’t Hold Your BreathContinue

With RFK Headed to HHS, What Should Pharma Advertisers be Thinking About?
News

With RFK Headed to HHS, What Should Pharma Advertisers be Thinking About?

November 19, 2024December 10, 2024

President-elect Donald Trump named Robert F. Kennedy Jr. as his pick to run the Department of Health and Human Services (HHS) when he returns to the White House. Kennedy has…

Read More With RFK Headed to HHS, What Should Pharma Advertisers be Thinking About?Continue

Enhancing ROI with Privacy-Compliant Pharma Marketing: Insights from BranchLab
Insights

Enhancing ROI with Privacy-Compliant Pharma Marketing: Insights from BranchLab

October 11, 2024October 11, 2024

As the landscape of healthcare advertising evolves, how can brands effectively reach their audiences while ensuring data privacy? Fierce Pharma’s Michelle Benz sought to find the answer to this pressing…

Read More Enhancing ROI with Privacy-Compliant Pharma Marketing: Insights from BranchLabContinue

Page navigation

1 2 Next PageNext
Data Solutions
  • HealthGraph™
  • Advertiser Solutions
  • Publisher Solutions
About
  • About
  • Careers
  • Contact
  • Follow Us

© BranchLab™ 2025, All Rights Reserved.   Privacy Policy • Terms & Conditions • Disclaimers • Do Not Sell My Information • PII Opt Out

  • Home
  • Data Solutions
    • Advertisers
    • Publishers
    • HealthGraph™
  • About
  • Resources
  • Careers